ErolA, PutgülG, SertE, MeteL: Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report. Turk Psikiyatri Derg, 24:140–144, 2013.
2.
GhaziuddinN, AlkhouriI, ChampineD, QuinlanP, FluentT, GhaziuddinM: ECT treatment of malignant catatonia/NMS in an adolescent: A useful lesson in delayed diagnosis and treatment. J ECT, 18:95–98, 2002.
3.
HermeshH, AizenbergD, WeizmanA: A successful electroconvulsive treatment of neuroleptic malignant syndrome. Acta Psychiatr Scand, 75:237–239, 1987.
4.
LuchiniF, MeddaP, MarianiMG, MauriM, ToniC, PerugiG: Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. World J Psychiatry, 22:182–192, 2015.
5.
SuY-P, ChangC-K, HayesRD, HarrisonS, LeeW, BroadbentM, TaylorD, StewartR: Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome. Acta Psychiatr Scand, 130:52–60, 2014.
6.
TrollorJN, SachdevPS: Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry, 33:650–659, 1999.